Literature DB >> 11319687

Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis.

J R Johnson1, T T O'Bryan, P Delavari, M Kuskowski, A Stapleton, U Carlino, T A Russo.   

Abstract

To identify bacterial predictors of recurrence and/or persistence in acute cystitis, extended virulence genotypes were compared with clonal background and epidemiologic status among 74 Escherichia coli urine isolates from women with first or recurrent episodes of urinary tract infection (UTI). Sequential isolates from patients with recurrent UTI were classified, using macrorestriction analysis, as having caused an isolated recurrence versus a single or multiple same-strain recurrences. papA, papG allele II, iha, and iutA predicted multiple same-strain recurrences, whereas nfaE and the absence of sfaS or fyuA predicted isolated recurrences. Phylogenetic group B2 accounted for 70% of isolates and for most of the putative virulence factors (VFs) studied. The meningitis-associated O18:K1:H7 clonal group comprised 18% of isolates, exhibited multiple VFs, and caused "once-only" recurrences less commonly than did other strains. These findings identify specific VFs and clonal groups against which preventive interventions might be beneficial and illustrate the importance of delineating pathogenetically relevant subgroups within the "recurrent cystitis" population.

Entities:  

Mesh:

Year:  2001        PMID: 11319687     DOI: 10.1086/320198

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

Review 1.  [Recurrent urinary tract infections in women. Virulence of pathogens and host reaction].

Authors:  T Oelschlaeger; R Fünfstück
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

2.  Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis.

Authors:  Lothar Beutin; Stefan Kaulfuss; Sylvia Herold; Eric Oswald; Herbert Schmidt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence.

Authors:  Anne E Robinson; James R Heffernan; Jeffrey P Henderson
Journal:  Future Microbiol       Date:  2018-06-05       Impact factor: 3.165

5.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Authors:  Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

6.  Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence.

Authors:  David C Bean; David M Livermore; Lucinda M C Hall
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays.

Authors:  Sadjia Bekal; Roland Brousseau; Luke Masson; Gabrielle Prefontaine; John Fairbrother; Josée Harel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.

Authors:  Konrad Trülzsch; Harald Hoffmann; Christiane Keller; Sören Schubert; Lutz Bader; Jürgen Heesemann; Andreas Roggenkamp
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.